Healthcare

#Clinical trials #Covid-19 #Healthcare #HIV #Malaria #Public health

World Health Day: We celebrate global drug discovery

As we celebrate World Health Day, Lu Rahman looks at some of the key drug discovery and development successes over the last year that have significantly helped improved the health and wellbeing of the global population.   Malaria breakthroughs  According to The World Health Organization (WHO) more than a million people in Africa… Read More

#Editor's Choice #Exclusive Content #News

#Clinical trials #Covid-19 #Healthcare #Public health

Interview: Delivering smart clinical trials for better health 

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the… Read More

#Covid-19 #Exclusive Content #News #Opinion

#Healthcare #Life sciences

New role to drive growth of CliniSys products and services globally 

Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally.  Moving forward  As the world looks to improve public health now and after the… Read More

#News

#Cancer #Cancer research #Comment #Healthcare #Public health

Close the care gap: World Cancer Day 2022 

2022's World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working to close this… Read More

#Cancer Research #Editor's Choice #Intelligence #News #Opinion #Trends & Analysis

#Cancer research #Healthcare #Public health #Regulatory

Leukaemia patients granted early access to investigational treatment 

Novartis UK has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given a positive scientific opinion for the investigational treatment asciminib to be made available to appropriate patients under the UK Early Access to Medicines Scheme (EAMS).1  What does this mean?  The… Read More

#News

#AI / data analytics / healthtech / informatics #Comment #Healthcare #Public health

Expert perspective: 2022 challenges and opportunities

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3 and many more internationally. Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

#Events #Healthcare

Global Healthcare 2022 conference now available for streaming 

Edison Group’s Edison Open House: Global Healthcare 2022 was a three-day event, in association with London Stock Exchange, global law firm Taylor Wessing and OpenExchange, which took place from January 25-27, focusing on 33 companies. Content is now available to stream.  Streaming   Content is now available… Read More

#News

#Clinical trials #Healthcare #Public health #Training

Psychotherapists begin training for treatment resistant depression trials 

Beckley Psytech has announced that the first cohort of psychotherapists have begun training in advance of the expected Phase II clinical trial examining 5-MeO-DMT-assisted psychotherapy in treatment resistant depression (TRD).   The training  The training is being conducted in collaboration with Fluence, an educational platform that provides professional… Read More

#News

#Drug discovery #Funding #Healthcare #Investment #Life sciences #Public health

Drug discovery investors: Who’s spending? 

While the research, results and trials often take centre-stage when it comes to drug discovery and development reporting, DDW’s Megan Thomas spotlights the funding and investments which make this possible.   1. US researcher awarded $3.6 million to study antibiotic resistance  Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News

#Data #Healthcare #Public health #Report #Study

Research reveals attitudes to Covid-19 treatment in the UK 

Pharmaceutical companies must keep improving Covid-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, a provider for the biopharma industry.   The report  This data, included in Informa Pharma’s ‘Q4… Read More

#Covid-19 #News

Patient receiving eye drops
#Clinical trials #Eye health #Healthcare #Therapeutics

Stuart Therapeutics Phase II clinical trial results of its dry eye candidate  

Stuart Therapeutics, a clinical stage, ophthalmic therapeutic development company, has announced the topline results of the first in human Phase II clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease.   The trial  The clinical trial, conducted between June and October… Read More

#News

#Covid-19 #Healthcare #Immunology / Virology & Vaccines #Public health

European Commission authorises Novavax Covid-19 vaccine

Novavax has been granted conditional marketing authorisation by the European Commission (EC) for Nuvaxovid Covid-19 vaccine.  Context  The vaccine is for active immunisation to prevent Covid-19 caused by SARS-CoV-2 in individuals 18 years of age and older and the authorisation follows the European Medicines Agency’s (EMA) Committee for Medicinal… Read More

#Covid-19 #News #Trending News

#Covid-19 #Healthcare #Immunology / Virology & Vaccines #Public health #Research

NIH scientists urge pursuit of universal coronavirus vaccine 

Physician-scientists of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have published a paper in The New England Journal of Medicine which suggests that in order to counter future coronavirus outbreaks, the global scientific and medical research community should focus… Read More

#News #Trending News

#Clinical trials #Covid-19 #Healthcare #Research

First UK trial to assess use of antivirals to treat Covid-19 set to begin 

The first clinical trial in the UK to investigate whether antiviral drugs could help reduce the severity of Covid-19 is due to start, led by the University of Oxford and delivered in Wales by Cardiff University in partnership with Public Health Wales and Health and Care Research Wales. Cardiff University staff… Read More

#News

#Drug development #Drug discovery #Healthcare #Library screening #Screening

TropIQ: Digitalising drug discovery for vector-borne diseases 

More than half of the world’s population is at risk from vector-borne diseases that are transmitted by insects such as mosquitoes, flies and ticks. These diseases cause more than one million deaths annually, and it is primarily people in the poorest countries who are the most vulnerable. Sophia Ktori shares insights fromTropIQ Health… Read More

#Editor's Choice #Exclusive Content #News

#Contraception #Healthcare #Public health

The first transdermal contraceptive patch licensed in the UK  

Gedeon Richter has become marketing authorisation holder for Evra, a once-weekly contraception for women of fertile age, which they say is the first and only transdermal contraceptive patch licenced in the UK.   Tamas Neubauer, Managing Director of UK and Ireland at Gedeon Richter, believes that the addition of a patch to their… Read More

#News #Trending News